
Enigma Genomics provides AI-powered genetic health insights directly to consumers using DNA testing. It uses CAP-accredited sequencing and AI-driven analysis to decode genomes and generate personalized reports. The company operates as a direct-to-consumer genetic testing platform with lifetime access to data and reports, serving both consumers and healthcare providers; technologies include genetic sequencing, artificial intelligence, data encryption, and SSL. Based in Dammam, Saudi Arabia, it positions itself among leading labs in the Middle East with data privacy standards aligned to HIPAA and ISO.

Enigma Genomics provides AI-powered genetic health insights directly to consumers using DNA testing. It uses CAP-accredited sequencing and AI-driven analysis to decode genomes and generate personalized reports. The company operates as a direct-to-consumer genetic testing platform with lifetime access to data and reports, serving both consumers and healthcare providers; technologies include genetic sequencing, artificial intelligence, data encryption, and SSL. Based in Dammam, Saudi Arabia, it positions itself among leading labs in the Middle East with data privacy standards aligned to HIPAA and ISO.